NEUROLITE DIN 02327848
Health Canada record
| Active ingredient(s) | BICISATE DIHYDROCHLORIDE 0.9 MG |
|---|---|
| Dosage form | Powder For Solution; Kit |
| Route | Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | V09A CENTRAL NERVOUS SYSTEM |
| Original market date | 29-Oct-1997 |
| Current status date | 04-Sep-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Lantheus MI Canada Inc — licence 101647, currently licensed, last inspection rating C (2023-05-03).
No Canadian shortage report is currently matched to this DIN.
Request a quote for NEUROLITE